Differential regulation of cyclin B1 RNA and protein expression during hepatocyte growth in vivo

Cell Growth and Differentiation

Volumn 7, Issue 7, 1996, Pages 903-916

  Trembley, Janeen H ^a,b   Ebbert, Jon O ^a   Kren, Betsy T ^a   Steer, Clifford J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B; RNA; SCATTER FACTOR;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL PROLIFERATION; IMMUNOHISTOCHEMISTRY; LIVER MICROSOME; LIVER REGENERATION; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS REGULATION; RAT; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIVISION; CYCLIN B; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; RNA, MESSENGER;

ANIMALIA; EUKARYOTA;

EID: 0029845482     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Pines, J. Cyclins and cyclin-dependent kinases: theme and variations. Adv. Cancer Res., 66: 181-212, 1995.
2. Lew, J., and Wang, J. H. Neuronal cdc2-like kinase. Trends Biochem. Sci., 20: 33-37, 1995.
3. cdc2, and H1-kinase activity in terminally differentiating lens fiber cells. Dev. Biol., 169: 185-194, 1995.
4. Kreutzer, M. A., Richards, J. P., De Silva-Udawatta, M. N., Temenak, J. J., Knoblich, J. A., Lehner, C. F., and Bennett, K. L. Caenorhabditis elegans cyclin A- and B-type genes: a cyclin A multigene family, an ancestral cyclin B3 and differential germline expression. J. Cell Sci., 108: 2415-2424, 1995.
5. Meikrantz, W., Gisselbrecht, S., Tam, S. W., and Schlegel, R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3754-3758, 1994.
6. cdo2 activation required for apoptosis. Science (Washington DC), 263: 1143-1145, 1994.
7. Fotedar, R., Flatt, J., Gupta, S., Margolis, R. L., Fitzgerald, P., Messier, H., and Fotedar, A. Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. Mol. Cell. Biol., 15: 932-942, 1995.
8. Elledge, S. J., and Harper, J. W. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol., 6: 847-852, 1994.
9. van Wijnen, A. J., Aziz, F., Graña, X., De Luca, A., Desai, R. K., Jaarsveld, K., Last, T. J., Soprano, K., Giordano, A., Lian, J. B., Stein, J. L., and Stein, G. S. Transcription of histone H4, H3, and HI cell cycle genes: promoter factor HINF-D contains CDC2, cyclin A, and an RB-related protein. Proc. Natl. Acad. Sci. USA, 91: 12882-12886, 1994.
10. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
11. cdc2. Cell, 63: 1013-1024, 1990.
12. cdc2 and its companion cyclin-dependent kinases. Trends Cell Biol., 3: 296-301, 1993.
13. Edgar, B. A., Sprenger, F., Duronio, R. J., Leopold, P., and O'Farrell, P. H. Distinct molecular mechanisms regulate cell cycle timing at successive stages of Drosophila embryogenesis. Genes Dev., 8: 440-452, 1994.
14. Gong, J., Traganos, F., and Darzynkiewicz, Z. Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DMA replication. Cell Growth & Differ., 6: 1485-1493, 1995.
15. Gong, J., Ardelt, B., Traganos, F., and Darzynkiewicz, Z. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res., 54: 4285-4288, 1994.
16. Fausto, N., and Webber, E. Liver regeneration. In: I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jakoby, D. A. Schachter, and D. A. Shafritz (eds.), The Liver Biology and Pathobiology, pp. 1059-1084. New York: Raven Press, Ltd., 1994.
17. Martinez-Hernandez, A., and Amenta, P. S. The extracellular matrix in hepatic regeneration. FASEB J., 9: 1401-1410, 1995.
18. Trembley, J. H., Kren, B. T., and Steer, C. J. Posttranscriptional regulation of cyclin B messenger RNA expression in the regenerating rat liver. Cell Growth & Differ., 5: 99-108, 1994.
19. cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase. FEBS Lett., 318: 331-334, 1993.
20. cdc2 with subcellular structures in Xenopus eggs. J. Cell Sci., 102: 285-297, 1992.
21. Pines, J., and Hunter, T. The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J., 13: 3772-3781, 1994.
22. Gallant, P., and Nigg, E. A. Identification of a novel vertebrate cyclin: cyclin B3 shares properties with both A- and B-type cyclins. EMBO J., 13: 595-605, 1994.
23. Lavery, D. J., and Schlbler, U. Circadian transcription of the cholesterol 7α hydroxylase gene may involve the liver-enriched bZIP protein DBP. Genes Dev., 7:1871-1884, 1993.
24. cdc13, a B-type cyclin, is associated with both the nucleolar and chromatin domains of the fission yeast nucleus. Mol. Biol. Cell, 4: 1087-1096, 1993.
25. Schmidt, E. E., and Schibler, U. Cell size regulation, a mechanism that controls cellular RNA accumulation: consequences on regulation of the ubiquitous transcription factors Oct1 and NF-Y and the liver-enriched transcription factor DBP. J. Cell Biol., 128: 467-483, 1995.
26. Jackman, M., Firth, M., and Pines, J. Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus. EMBO J., 14: 1646-1654, 1995.
27. cdc2 Kinase to microtubules and is a potential regulator of M-phase microtubule dynamics. J. Cell Biol., 128: 849-862, 1995.
28. Thomas, L, Clarke, P. R., Pagano, M., and Gruenberg, J. Inhibition of membrane fusion in vitro via cyclin B but not cyclin A. J. Biol. Chem., 267: 6183-6187, 1992.
29. Maity, A., McKenna, W. G., and Muschel, R. J. Evidence for posttranscriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J., 14: 603-609, 1995.
30. Ross, J. mRNA stability in mammalian cells. Microbiol. Rev., 59: 423-450, 1995.
31. Beckett, R. B., Weiss, R., Stitzel, R. E., and Cenedella, R. J. Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate. Toxicol. Appl. Pharmacol., 23: 42-53, 1972.
32. Bursch, W., Lauer, B., Timmermann-Trosiener, I., Barthel, G., Schuppler, J., and Schulte-Hermann, R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis (Lond.), 5: 453-458, 1984.
33. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA, 89: 5408-5412, 1992.
34. O state. Oncogene, 10: 1343-1351, 1995.
35. Winstall, E., Gamache, M., and Raymond, V. Rapid mRNA degradation mediated by the c-fos 3′ AU-rich element and that mediated by the granulocyte-macrophage colony-stimulating factor 3′ AU-rich element occur through similar polysome-associated mechanisms. Mol. Cell. Biol., 15: 3796-3804, 1995.
36. Lee, C. H., Bradley, G., and Ling, V. Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability. Cell Growth & Differ., 6: 347-354, 1995.
37. Hovland, R., Campbell, G., Pryme, I., and Hesketh, J. The mRNAs for cyclin A, c-myc and ribosomal proteins L4 and S6 are associated with cytoskeletal-bound polysomes in HepG2 cells. Biochem. J., 310: 193-196, 1995.
38. Lu, X. P., Koch, K. S., Lew, D. J., Dulic, V., Pines, J., Reed, S. I., Hunter, T., and Leffert, H. L. Induction of cyclin mRNA and cyclin-associated histone H1 kinase during liver regeneration. J. Biol. Chem., 267: 2841-2844, 1992.
39. Albrecht, J. H., Hoffman, J. S., Kren, B. T., and Steer, C. J. Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regenerating liver and human liver diseases. Am. J. Physiol., 265: G857-G864, 1993.
40. Loyer, P., Glaise, D., Cariou, S., Baffet, G., Meijer, L., and Guguen-Guillouzo, C. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J. Biol. Chem., 269: 2491-2500, 1994.
41. Albrecht, J. H., Hu, M. Y., and Cerra, F. B. Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem. Biophys. Res. Commun., 209: 648-655, 1995.
42. Datta, N. S., Williams, J. L., Caldwell, J., Curry, A. M., Ashcraft, E. K., and Long, M. W. Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol. Biol. Cell, 7: 209-223, 1996.
43. Kislauskis, E. H., Li, Z., Singer, R. H., and Taneja, K. L. Isoform-specific 3′-untranslated sequences sort α-cardiac and β-cytoplasmic actin messenger RNAs to different cytoplasmic compartments. J. Cell Biol., 123: 165-172, 1993.
44. Kislauskis, E. H., Zhu, X., and Singer, R. H. Sequences responsible for intracellular localization of β-actin messenger RNA also affect cell phenotype. J. Cell Biol., 127: 441-451, 1994.
45. Dalby, B., and Glover, D. M. 3′ non-translated sequences in Drosophila cyclin B transcripts direct posterior pole accumulation late in oogenesis and peri-nuclear association in syncytial embryos. Development (Camb.), 115: 989-997, 1992.
46. Darzynkiewicz, Z., Gong, J., and Traganos, F. Analysis of DNA content and cyclin protein expression in studies of DNA ploidy, growth fraction, lymphocyte stimulation, and the cell cycle. Methods Cell Biol., 41: 421-435, 1994.
47. Häussinger, D., Hallbrucker, C., vom Dahl, S., Decker, S., Schweizer, U., Lang, F., and Geork, W. Cell volume is a major determinant of proteolysis control in liver. FEBS Lett., 283: 70-72, 1991.
48. Yoshizumi, M., Lee, W., Hsieh, C., Tsai, J., Li, J., Perrella, M. A., Patterson, C., Endege, W. O., Schlegel, R., and Lee, M. Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J. Clin. Invest., 95: 2275-2280, 1995.
49. Smith, E., Frenkel, B., Schlegel, R., Giordano, A., Lian, J. B., Stein, J. L., and Stein, G. S. Expression of cell cycle regulatory factors in differentiating osteoblasts: postproliferative up-regulation of cyclins B and E. Cancer Res., 55: 5019-5024, 1995.
50. CDC25 is a nuclear protein required for the initiation of mitosis in human cells. Proc. Natl. Acad. Sci. USA, 88: 10500-10504, 1991.
51. Girard, F., Strausfeld, U., Cavadore, J-C., Russell, P., Femandez, A., and Lamb, N. J. cdc25 is a nuclear protein expressed constitutively throughout the cell cycle in nontransformed mammalian cells. J. Cell Biol., 118: 785-794, 1992.
52. McGowan, C. H., Russell, P., and Reed, S. I. Periodic biosynthesis of the human M-phase promoting factor catalytic subunit p34 during the cell cycle. Mol. Cell. Biol., 10: 3847-3851, 1990.
53. Cdc2 tyrosine phosphorylation. EMBO J., 14: 2760-2771, 1995.
54. Holloway, S. L., Glotzer, M., King, R. W., and Murray, A. W. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell, 73: 1393-1402, 1993.
55. 2 arrest. Mol. Cell. Biol., 13: 6640-6652, 1993.
56. 2/M phases. J. Biol. Chem., 270: 9281-9288, 1995.
57. DeCaprio, J. A., Furukawa, Y., Ajchenbaum, F., Griffin, J. D., and Livingston, D. M. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci. USA, 89: 1795-1798, 1992.
58. Lin, B. T. Y., and Wang, J. Y. J. Cell cycle regulation of retinoblastoma protein phosphorylation. Ciba Found. Symp., 170: 227-243, 1992.
59. Mittnacht, S., Lees, J. A., Desai, D., Harlow, E., Morgan, D. O., and Weinberg, R. A. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J., 13: 118-127, 1994.
60. Fan, G., Xu, R., Wessendorf, M. W., Ma, X., Kren, B. T., and Steer, C. J. Modulation of retinoblastoma and retinoblastoma-related proteins in regenerating rat liver and primary hepatocytes. Cell Growth & Differ., 6: 1463-1476, 1995.
61. Fan, G., Ma, X., Kren, B. T., and Steer, C. J. The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene, 12: 1909-1919, 1996.
62. Raff, M. C. Social controls on cell survival and cell death. Nature (Lond.), 356: 397-400, 1992.
63. Ishizaki, Y., Cheng, L., Mudge, A. W., and Raff, M. C. Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol. Biol. Cell, 6: 1443-1458, 1995.
64. Bursch, W., Paffe, S., Putz, B., Barthel, G., and Schulte-Hermann, R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (Lond.), 11: 847-853, 1990.
65. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. Lethal effect of the anti-Fas antibody in mice. Nature (Lond.), 364: 806-809, 1993.
66. Ledda-Columbano, G. M., Coni, P., Faa, G., Manenti, G., and Columbano, A. Rapid induction of apoptosis in rat liver by cycloheximide. Am. J. Pathol., 140: 545-549, 1992.
67. Chen, G., Shi, L. F., Litchfield, D. W., and Greenberg, A. H. Rescue from granzyme B-induced apoptosis by weel kinase. J. Exp. Med., 181: 2295-2300, 1995.
68. Steinmann, K. E., Pei, X. F., Stöppler, H., Schlegel, R., and Schlegel, R. Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes. Oncogene, 9: 387-394, 1994.
69. cdc2 and apoptosis. Science (Washington DC), 269: 106-107, 1995.
70. Ohkubo, Y., Kishimoto, T., Nakata, T., Yasuda, H., and Endo, T. SV40 large T antigen reinduces the cell cycle in terminally differentiated myotubes through inducing Cdk2, Cdc2, and their partner cyclins. Exp. Cell Res., 214: 270-278, 1994.
71. Higgins, G. M., and Anderson, R. M. Experimental pathology of the liver: I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol., 12: 186-202, 1931.
72. Kren, B. T., Kumar, N. M., Wang, S-q., Gilula, N. B., and Steer, C. J. Differential regulation of multiple gap junction transcripts and proteins during rat liver regeneration. J. Cell Biol., 123: 707-718, 1993.
73. Saccomanno, C. F., Bordonaro, M., Chen, J. S., and Nordstrom, J. L. A faster ribonuclease protection assay. BioTechniques, 13: 846-850, 1992.
74. Chen, X., Sparks, J. D., Yao, Z., and Fisher, E. A. Hepatic polysomes that contain apoprotein B mRNA have unusual physical properties. J. Biol. Chem., 268: 21007-21013, 1993.
75. Luthe, D. S. A simple technique for the preparation and storage of sucrose gradients. Anal. Biochem., 135: 230-232, 1983.
76. Brewer, G., and Ross, J. Messenger RNA turnover in cell-free extracts. Methods Enzymol., 181: 202-209, 1990.
77. Beebee, T. J. C. Nucleoli and preribosomal ribonucleoprotein particles. In: A. J. MacGillivray and G. D. Birnie (eds.), Nuclear Structures: Isolation and Characterization, pp. 100-117. London: Butterworth & Co., Ltd., 1986.
78. Katz, D. A., Theodorakis, N. G., Cleveland, D. W., Lindsten, T., and Thompson, C. B. AU-A, an RNA-binding activity distinct from hnRNP A1, is selective for AUUUA repeats and shuttles between the nucleus and trie cytoplasm. Nucleic Acids Res., 22: 238-246, 1994.
79. Harlow, E., and Lane, D. Antibodies. A Laboratory Manual. New York: Cold Spring Harbor Laboratory, 1988.